Lourens Jan Dirk Zaneveld
Veterinary in Chicago, IL

5925621, Jul 20, 1999

Oct 14, 1997

8/949793

Lourens Jan Dirk Zaneveld - Chicago IL
Robert Anthony Anderson - Chicago IL
Xiao Hui Diao - Chicago IL
Paul Robert Young - Oak Park IL
Donald Paul Waller - Oakbrook IL
Sanjay Garg - Chicago IL
Calvin J. Chany - Bolingbrook IL

Rush-Presbyterian, St. Luke's Medical Center - Chicago IL

A61K 4304

514 27

A method for the reduction in the risk of transmitting a sexually transmitted disease--especially HIV and/or HSV--during sexual activity is provided. This method generally comprises the application of an effective amount of an inhibitory agent, preferably as a topical formulation, to the area or areas of sexual contact prior to engaging in sexual activity. Inhibitory agents which are useful in the present invention include, for example, phosphorylated hesperidins, sulfonated hesperidins, polystyrene sulfonates, substituted benzenesulfonic acid formaldehyde co-polymers, H. sub. 2 SO. sub. 4 -modified mandelic acids, and the like. This method can be used by heterosexuals, homosexuals, and/or bisexuals engaged in a wide variety of sexual activities. In addition to anti-STD activity, these agents may also act as vaginal contraceptives; moreover, they generally have fewer side effects than conventional vaginal contraceptives (e. g. , nonoxynol-9).

5932619, Aug 3, 1999

Nov 7, 1997

8/965935

Lourens Jan Dirk Zaneveld - Chicago IL
Robert Anthony Anderson - Chicago IL
Xiao Hui Diao - Chicago IL
Paul Robert Young - Oak Park IL
Donald Paul Waller - Oakbrook IL
Sanjay Garg - Chicago IL
Calvin J. Chany - Bolingbrook IL
Darrick S. H. L. Kim - Chicago IL

Rush-Presbyterian, St. Luke's Medical Center - Chicago IL

A61K 3710

514570

A method for the reduction in the risk of transmitting a sexually transmitted disease--especially HIV and/or HSV--during sexual activity is provided. This method generally comprises the application of an effective amount of an inhibitory agent, preferably as a topical formulation, to the area or areas of sexual contact prior to engaging in sexual activity. Inhibitory agents which are useful in the present invention include, for example, phosphorylated hesperidins, sulfonated hesperidins, polystyrene sulfonates, substituted benzenesulfonic acid formaldehyde co-polymers, H. sub. 2 SO. sub. 4 -modified mandelic acids, and the like. This method can be used by heterosexuals, homosexuals, and/or bisexuals engaged in a wide variety of sexual activities. In addition to anti-STD activity, these agents may also act as vaginal contraceptives; moreover, they generally have fewer side effects than conventional vaginal contraceptives (e. g. , nonoxynol-9).

6028115, Feb 22, 2000

Feb 3, 1999

9/243035

Lourens Jan Dirk Zaneveld - Chicago IL
Robert Anthony Anderson - Chicago IL
Xiao Hui Diao - Chicago IL
Paul Robert Young - Oak Park IL
Donald Paul Waller - Oakbrook IL
Sanjay Garg - Chicago IL
Calvin J. Chany - Bolingbrook IL

Rush-Presbyterian-St. Luke's Medical Center - Chicago IL

A01N 3110, A01N 3500, A01N 3114, A61K 3174, A61K 4748

514709

A method for the reduction in the risk of transmitting a sexually transmitted disease--especially HIV and/or HSV--during sexual activity is provided. This method generally comprises the application of an effective amount of an inhibitory agent, preferably as a topical formulation, to the area or areas of sexual contact prior to engaging in sexual activity. Inhibitory agents which are useful in the present invention include, for example, phosphorylated hesperidins, sulfonated hesperidins, polystyrene sulfonates, substituted benzenesulfonic acid formaldehyde co-polymers, H. sub. 2 SO. sub. 4 -modified mandelic acids, and the like. This method can be used by heterosexuals, homosexuals, and/or bisexuals engaged in a wide variety of sexual activities. In addition to anti-STD activity, these agents may also act as vaginal contraceptives; moreover, they generally have fewer side effects than conventional vaginal contraceptives (e. g. , nonoxynol-9).

6239182, May 29, 2001

Feb 18, 1999

9/252417

Lourens Jan Dirk Zaneveld - Chicago IL
Robert Anthony Anderson - Chicago IL
Xiao Hui Diao - Chicago IL
Paul Robert Young - Oak Park IL
Donald Paul Waller - Oakbrook IL
Sanjay Garg - Chicago IL
Calvin J. Chany - Bolingbrook IL

Rush-Presbyterian-St. Lukes Medical Center - Chicago IL

A61K 31015

514764

A method for the reduction in the risk of transmitting a sexually transmitted disease--especially HIV and/or HSV--during sexual activity is provided. This method generally comprises the application of an effective amount of an inhibitory agent, preferably as a topical formulation, to the area or areas of sexual contact prior to engaging in sexual activity. Inhibitory agents which are useful in the present invention include, for example, phosphorylated hesperidins, sulfonated hesperidins, polystyrene sulfonates, substituted benzenesulfonic acid formaldehyde co-polymers, H. sub. 2 SO. sub. 4 -modified mandelic acids, and the like. This method can be used by heterosexuals, homosexuals, and/or bisexuals engaged in a wide variety of sexual activities. In addition to anti-STD activity, these agents may also act as vaginal contraceptives; moreover, they generally have fewer side effects than conventional vaginal contraceptives (e. g. , nonoxynol-9).